Tampa, Fla-based Anodyne Therapy LLC has announced a resolution of its lawsuit against ICP Educational Resources, which conducts business as Fasterhealing.com, and is the distributor of the RevitaMed and RevitaLight brands (RevitaMed).
Upon agreement by the parties, the United States District Court for the Middle District of Florida entered a Judgment, Permanent Injunction, Findings of Fact and Conclusions of Law against ICP and its principal, Tom Neuman. The Judgment stated that the patents protecting Anodyne Therapys technology, (Nos. 5,358,503 and 6,607,550) are valid and enforceable and that ICPs RevitaMed Devices, when used as intended, infringed Anodynes patents.
The Judgment further stated that Anodyne Therapys trademark, ANODYNE, is valid and enforceable and that certain marketing materials and actions by ICP violated federal law and infringed the ANODYNE trademark. As a result of the Judgment and the agreement between the parties, ICP has ceased promotion and sales of the RevitaMed Devices. Furthermore, ICP is permanently enjoined from manufacturing, distributing, offering for sale or selling any infrared devices that infringe Anodynes patents and is enjoined from using or displaying, except as a fair use, the ANODYNE Mark and/or the MIRE Mark.
We are extremely pleased with this outcome, and we remain committed to vigorously protecting our patents and trademarks, said Craig Turtzo, CEO.
Anodyne Therapy technology is currently available nationwide at more than 5,000 outpatient therapy facilities, hospitals, nursing homes, physician offices and home health agencies as part of a comprehensive program to improve functional outcomes for patients suffering from painful, circulatory conditions caused by diabetes and other chronic conditions. Products are also available for convenient home use. For more information, visit www.anodynetherapy.com.
